Product Information
WOMEN'S GENTLE LAX EC 5 MG TAB is a generic product labeled by AmerisourceBergen, priced at $0.0374 per EA under NDC 46122042963. Its NADAC has been published 405 times since Feb 20, 2019.
Strength
5 mg/1
Manufacturer
AmerisourceBergenNDC
46122042963
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
11/18/2026
Active Ingredients
BISACODYLApproval Type
OTC MONOGRAPH DRUG
FDA Application
505G(a)(3)On Market Since
4/1/2013
Pharmacological Classes
Price Statistics
The NADAC for WOMEN'S GENTLE LAX EC 5 MG TAB has been published 405 times since Feb 20, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0374 per EA |
|---|---|
| All-time high | $0.0575 (Jun 16, 2021) |
| All-time low | $0.0315 (Jul 21, 2021) |
| 52-week high | $0.0464 |
| 52-week low | $0.0350 |
| Median price | $0.0387 |
| Average price | $0.0401 |
| Largest weekly change | +41.1% (Jan 18, 2023) |
| Weeks tracked | 405 |
| Tracking since | Feb 20, 2019 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bisacodyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Stimulant Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of WOMEN'S GENTLE LAX EC 5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for WOMEN'S GENTLE LAX EC 5 MG TAB, manufactured by AmerisourceBergen, is $0.0374 per EA (NDC 46122042963), effective Nov 18, 2026.
How has the price of WOMEN'S GENTLE LAX EC 5 MG TAB changed over time?
Over the history we have for it, the NADAC for WOMEN'S GENTLE LAX EC 5 MG TAB has held within roughly two percent of its current level. It has been tracked across 405 weekly CMS publications since Feb 20, 2019.
What are the highest and lowest recorded NADAC prices for WOMEN'S GENTLE LAX EC 5 MG TAB?
Since Feb 20, 2019, the NADAC for WOMEN'S GENTLE LAX EC 5 MG TAB has ranged from a low of $0.0315 (Jul 21, 2021) to a high of $0.0575 (Jun 16, 2021), with a median of $0.0387 per EA.
Are there cheaper alternatives to WOMEN'S GENTLE LAX EC 5 MG TAB?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM LAXATIVE EC 5 MG TABLET, is $0.0372 per EA — about 1% below WOMEN'S GENTLE LAX EC 5 MG TAB.
Who manufactures WOMEN'S GENTLE LAX EC 5 MG TAB?
WOMEN'S GENTLE LAX EC 5 MG TAB (NDC 46122042963) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.